Check out an article from OSHU, where Dr. Alison Skalet and her team have been hard at work researching CHCs – a promising new bloodbiomarker to anticipate metastatic disease in patients following treatment of the eye but prior to metastasis showing up elsewhere in the body.

https://www.ohsu.edu/casey-eye-institute/new-clues-metastasis-ocular-melanoma

More information on CHCs below.